| 1 |
Severskaya NV, Nevolskikh AA, Avdeenko VA, Hailova ZV, Ivanov SA. Fecal occult blood testing in colorectal cancer screening programs. Issled prakt med (Print) 2022;9:145-159. [DOI: 10.17709/2410-1893-2022-9-3-11] [Reference Citation Analysis]
|
| 2 |
Clark GR, Steele RJ, Fraser CG. Strategies to minimise the current disadvantages experienced by women in faecal immunochemical test-based colorectal cancer screening. Clinical Chemistry and Laboratory Medicine (CCLM) 2022;0. [DOI: 10.1515/cclm-2022-0583] [Reference Citation Analysis]
|
| 3 |
Wang L, Liu C, Wang Y, Du L. Cost-effectiveness of risk-tailored screening strategy for colorectal cancer: A systematic review. J Gastroenterol Hepatol 2022;37:1235-43. [PMID: 35434850 DOI: 10.1111/jgh.15860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Tourne-Garcia C, Perez-Riquelme F, Monteagudo-Piqueras O, Fraser CG, Yepes-Garcia P. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain). J Med Screen 2022;:9691413221094919. [PMID: 35578555 DOI: 10.1177/09691413221094919] [Reference Citation Analysis]
|
| 5 |
Hunt N, Rao C, Logan R, Chandrabalan V, Oakey J, Ainsworth C, Smith N, Banerjee S, Myers M. A cohort study of duplicate faecal immunochemical testing in patients at risk of colorectal cancer from North-West England. BMJ Open 2022;12:e059940. [PMID: 35418441 DOI: 10.1136/bmjopen-2021-059940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Njor SH, Rasmussen M, Friis-Hansen L, Andersen B. Varying fecal immunochemical test screening cutoffs by age and gender: a way to increase detection rates and reduce the number of colonoscopies. Gastrointest Endosc 2022;95:540-9. [PMID: 34626590 DOI: 10.1016/j.gie.2021.09.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Tran TN, Peeters M, Hoeck S, Van Hal G, Janssens S, De Schutter H. Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the “interval cancer” perspective. Br J Cancer. [DOI: 10.1038/s41416-021-01694-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 8 |
Chen CH, Tsai MK, Wen C, Wen CP. A user-friendly objective prediction model in predicting colorectal cancer based on 234 044 Asian adults in a prospective cohort. ESMO Open 2021;6:100288. [PMID: 34808523 DOI: 10.1016/j.esmoop.2021.100288] [Reference Citation Analysis]
|
| 9 |
Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ 2021;374:n1855. [PMID: 34526356 DOI: 10.1136/bmj.n1855] [Cited by in Crossref: 63] [Cited by in F6Publishing: 30] [Article Influence: 31.5] [Reference Citation Analysis]
|
| 10 |
Thomas C, Mandrik O, Saunders CL, Thompson D, Whyte S, Griffin S, Usher-Smith JA. The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis. Cancer Prev Res (Phila) 2021;14:811-22. [PMID: 34039685 DOI: 10.1158/1940-6207.CAPR-20-0620] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 11 |
Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;325:1978-98. [PMID: 34003220 DOI: 10.1001/jama.2021.4417] [Cited by in Crossref: 107] [Cited by in F6Publishing: 67] [Article Influence: 53.5] [Reference Citation Analysis]
|
| 12 |
Hakim GD. Information on Colon Polyps in Terms of Gastroenterology. Colon Polyps and Colorectal Cancer 2021. [DOI: 10.1007/978-3-030-57273-0_6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Senore C, Zorzi M. Do We Need a New Paradigm for Assessing the Accuracy of Fecal Immunochemical Test Screening? Clin Gastroenterol Hepatol 2020;18:2873-5. [PMID: 32289539 DOI: 10.1016/j.cgh.2020.04.008] [Reference Citation Analysis]
|
| 14 |
Digby J, O'Carroll RE, Chambers JA, Steele RJC. The impact of hypothetical PErsonalised Risk Information on informed choice and intention to undergo Colorectal Cancer screening colonoscopy in Scotland (PERICCS)-a randomised controlled trial. BMC Med 2020;18:285. [PMID: 33076932 DOI: 10.1186/s12916-020-01750-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 15 |
Berry E, Miller S, Koch M, Balasubramanian B, Argenbright K, Gupta S. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens. Clin Gastroenterol Hepatol 2020;18:647-53. [PMID: 31085338 DOI: 10.1016/j.cgh.2019.04.077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Chen M, Chang H, Chong L, Liu Y, Sun C, Yang K, Lin Y. Relatively low risk and nonaggressive stage of colorectal cancer in individuals with negative baseline fecal immunochemical test results: A cohort study. Adv in Digestive Med 2021;8:19-26. [DOI: 10.1002/aid2.13169] [Reference Citation Analysis]
|
| 17 |
Niedermaier T, Balavarca Y, Brenner H. Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis. Am J Gastroenterol 2020;115:56-69. [PMID: 31850933 DOI: 10.14309/ajg.0000000000000465] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 18 |
Hull MA, Rees CJ, Sharp L, Koo S. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol 2020;17:773-80. [PMID: 33067592 DOI: 10.1038/s41575-020-00368-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 19 |
Selby K, Levine EH, Doan C, Gies A, Brenner H, Quesenberry C, Lee JK, Corley DA. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis. Gastroenterology 2019;157:1494-505. [PMID: 31472152 DOI: 10.1053/j.gastro.2019.08.023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 20 |
Brenner H, Gies A, Selby K. Overestimated Sensitivity of Fecal Immunochemical Tests in Screening Cohorts With Registry-Based Follow-up. Am J Gastroenterol 2019;114:1795-801. [PMID: 31658130 DOI: 10.14309/ajg.0000000000000412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 21 |
Barnes DE, Zhou J, Walker RL, Larson EB, Lee SJ, Boscardin WJ, Marcum ZA, Dublin S. Development and Validation of eRADAR: A Tool Using EHR Data to Detect Unrecognized Dementia. J Am Geriatr Soc 2020;68:103-11. [PMID: 31612463 DOI: 10.1111/jgs.16182] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 22 |
Hoff G, Ursin G, Løberg M, de Lange T, Skovlund E, Holme Ø. Continuous development of colorectal cancer screening programs. Acta Oncol 2019;58:822-3. [PMID: 30939973 DOI: 10.1080/0284186X.2019.1588475] [Reference Citation Analysis]
|
| 23 |
Masood U, Dhamoon AS, Murthy U. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection. Ann Intern Med 2019;170:736. [PMID: 31108528 DOI: 10.7326/L19-0094] [Reference Citation Analysis]
|
| 24 |
Imperiale TF, Gruber RN, Stump TE, Emmett TW, Monahan PO. Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps: A Systematic Review and Meta-analysis. Ann Intern Med 2019;170:319-29. [PMID: 30802902 DOI: 10.7326/M18-2390] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 25.3] [Reference Citation Analysis]
|
